A few days ago, the General Office of the National Health and Family Planning Commission issued a notice to publish management specifications and quality control indicators for 15 “limited clinical applications†medical technologies such as hematopoietic stem cell transplantation. Medical institutions should have these conditions in order to carry out relevant technologies.
According to the notice, "restricted clinical application" medical technology includes hematopoietic stem cell transplantation technology, allogeneic islet transplantation technology, allogeneic motor system structural tissue transplantation technology, allogeneic corneal transplantation technology, allogeneic skin transplantation technology, gender reset Technology, proton and heavy ion accelerator radiotherapy technology, radioactive particle implantation therapy technology, deep tumor hyperthermia and whole body hyperthermia technology, tumor ablation therapy technology, ventricular assisted technology, artificial intelligence assisted diagnosis technology, artificial intelligence assisted therapy technology, cranial Craniofacial surgery for maxillofacial deformity and craniofacial combined radical treatment for oral and maxillofacial tumors.
The 15 medical technology management regulations clarify the basic requirements and training management requirements for medical institutions, personnel, and technology management. For example, a medical institution that carries out hematopoietic stem cell transplantation technology should have more than 4 beds in a class of laminar flow wards, and a medical institution that carries out child hematopoietic stem cell transplantation technology in adult blood medicine departments should also have at least one deputy chief physician or above pediatrician. Medical institutions should perform non-blood, cord blood or matched hematopoietic stem cell transplantation after completing 5 cases of sibling allogeneic hematopoietic stem cell transplantation.
The specification also requires that physicians who perform hematopoietic stem cell transplantation technology should have more than 10 years of experience in clinical diagnosis and treatment in the Department of Hematology or Pediatrics, participate in hematopoietic stem cell transplantation for more than 5 years, and have the ability to diagnose and treat hematopoietic stem cell transplantation complications. Departments with less than 10 hundred-level laminar flow ward beds shall be equipped with more than 3 licensed medical practitioners who have passed the hematopoietic stem cell transplantation technology training, and nurses shall be equipped according to the nurse to bed ratio of 2:1; 10 or more hundred laminar flow ward beds. The department should be equipped with more than 5 qualified medical practitioners trained in hematopoietic stem cell transplantation technology, and nurses should be equipped according to the nurse-bed ratio of 1.7:1.
Feline Infectious Peritonitis (FIP), referred to as Feline Infectious Peritonitis (FIP), is a fatal abnormal immune response that occurs in cats. It is caused by the mutation of the feline coronavirus carried by cats. As a high-incidence and fatal disease of pet cats, the current incidence of feline abdominal transmission is about 10%.
The symptoms of cats are usually divided into two categories, namely wet FIP and dry FIP, of which wet FIP accounts for the majority of all cases. About 70%, manifested as abdominal pleural effusion, abnormal bulging; dry FIP cats have different symptoms, depending on the type of organ affected by the virus.
So far, all feline feline feline treatments are based on the characteristics of the disease, and GS-441524 can play a role in the treatment of feline feline disease. Therefore, the therapeutic effect of GS-441524 is obviously more ideal, the dose used is less, the treatment cycle is shorter, and the efficacy, safety and convenience of operation are all good. Because of this, GS-441524 is considered by many pet owners and veterinarians to be a magic medicine that can effectively treat feline abdominal infection.
Gs 441524 Fip,Fip Treatment Gs441,Gs 441524 Fipv Cats,Gs 441524 For Fip
XI AN RHINE BIOLOGICAL TECHNOLOGY CO.,LTD , https://www.rhinebioteches.com